| ID | Sequence | Length | GC content |
|---|---|---|---|
| lnc-NCR3LG1-1:1 | CAUUAAUAUUUAAAAUGUUUUUUAAAGCCACUGUUUUAUACUGGCUUUG… | 1144 nt | 0.4519 |
| lnc-NCR3LG1-1:2 | CUAAUUUUUUGUUGUUGUUGUUGUUGCGAUAAGGUCUCGCUGUAUUGUC… | 2883 nt | 0.4842 |
| lnc-NCR3LG1-1:3 | GGAUUACAGGCAUGAGCCACUGUGCCUGGCCUAGUAUUGGUCAUUAGUA… | 788 nt | 0.4048 |
| lnc-NCR3LG1-1:4 | AAGAGCACACUGUUGCAGCUGCCCUCCUUGGAUGGAACUAUGGAAUGAU… | 2126 nt | 0.5033 |
No relevant information is available at the moment.
A study in humans identified a competing endogenous RNA network associated with myocardial ischemia-reperfusion injury following percutaneous coronary intervention, where the lnc-NCR3LG1-1 was mentioned in the introduction and discussion as a potential biomarker for myocardial infarction occurrence [Liu et al. DOI:10.1111/jcmm.14163].